Trust Company’s DexCom DXCM Stock Holding History

Trust Company’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$431	Hold	5	–	–	﹤0.01%	783
2026 Q2	$337	Hold	5	–	–	﹤0.01%	831
2026 Q1	$314	Hold	5	–	–	﹤0.01%	817
2025 Q4	$332	Buy	+5	New	+$323	﹤0.01%	808

Other funds holding DXCM

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

HWG Holdings Houston, Texas $434M AUM 42.17% 1-Year Est. Return

Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return

WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return

Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return

Argus Investors Counsel New York $129M AUM 31.03% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

HF Advisory Group Annapolis, Maryland $336M AUM 14.9% 1-Year Est. Return

Trust Company's DXCM Position: Q3 2026 in Review

Trust Company held its DexCom (DXCM) position steady in Q3 2026 at 5 shares worth $431. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Trust Company first reported a position in DXCM in Q4 2025 and has held it in 4 quarters since. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

Trust Company held 5 shares of DexCom worth $431 as of Q3 2026.
Trust Company left its DexCom share count unchanged in Q3 2026.
DexCom made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #783 holding.
Trust Company first reported a position in DexCom in Q4 2025 and has held it in 4 quarters since.
41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.